Cargando…

Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?

Chloroquine and hydroxychloroquine belong to the aminoquinoline drugs. Studies revealed that chloroquine and hydroxychloroquine shows antagonism activity against COVID-19 under laboratory conditions. ARDS and ALI are conditions that occur in patients with COVID-19 as the main pathological complicati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bahadoram, Mohammad, Keikhaei, Bijan, Saeedi-Boroujeni, Ali, Mahmoudian-Sani, Mohammad-Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792551/ https://www.ncbi.nlm.nih.gov/pubmed/33416933 http://dx.doi.org/10.1007/s00210-020-02034-6

Ejemplares similares

Radiographic Features of the Maxillofacial Anomalies in Beta-Thalassemia Major: With New View
por: Bayati, Soheyla, et al.
Publicado: (2021)

miRNA-223 as a regulator of inflammation and NLRP3 inflammasome, the main fragments in the puzzle of immunopathogenesis of different inflammatory diseases and COVID-19
por: Houshmandfar, Sheyda, et al.
Publicado: (2021)

Anti-inflammatory potential of Quercetin in COVID-19 treatment
por: Saeedi-Boroujeni, Ali, et al.
Publicado: (2021)

COVID-19 Pandemic along with Pandemic of Lifestyle-Associated Diseases Victimizes Patients in an Inflammation Context!
por: Saeedi-Boroujeni, Ali, et al.
Publicado: (2020)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
por: Ho, Tzu-Chuan, et al.
Publicado: (2021)

Hydroxyurea: Clinical and Hematological Effects in Patients With Sickle Cell Anemia
por: Keikhaei, Bijan, et al.
Publicado: (2016)

Tranilast as an Adjunctive Therapy in Hospitalized Patients with Severe COVID- 19: A Randomized Controlled Trial
por: Saeedi-Boroujeni, Ali, et al.
Publicado: (2022)

Chloroquine, hydroxychloroquine and COVID-19
por: Erickson, T. B., et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine in the context of COVID-19
por: Shukla, Ashutosh M, et al.
Publicado: (2020)

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020)

Progranulin (PGRN) as a regulator of inflammation and a critical factor in the immunopathogenesis of cardiovascular diseases
por: Saeedi-Boroujeni, Ali, et al.
Publicado: (2023)

Pharmacology of Chloroquine and Hydroxychloroquine
por: Browning, David J.
Publicado: (2014)

Chloroquine/hydroxychloroquine overdose
por: McKeever, Rita
Publicado: (2020)

Risks of chloroquine or hydroxychloroquine use for COVID-19
Publicado: (2020)

COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?
por: Marmor, Michael F.
Publicado: (2020)

COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?
por: Marmor, Michael F.
Publicado: (2020)

Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic()
por: Jáuregui, Edwin
Publicado: (2021)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
por: Mahmoudi, Javad, et al.
Publicado: (2021)

Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19
por: Singh, Bhagteshwar, et al.
Publicado: (2021)

Evidence for Chloroquine/Hydroxychloroquine in the Treatment of COVID-19
por: Shetty, Rajesh M, et al.
Publicado: (2021)

Chloroquine or Hydroxychloroquine for COVID‐19: Is Cardiotoxicity a Concern?
por: Kamp, Timothy J., et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection
por: Carafoli, Ernesto
Publicado: (2021)

Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19
por: Gevers, S., et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
por: Colson, Philippe, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine increase risk of death in COVID-19
Publicado: (2020)

Chloroquine and hydroxychloroquine for COVID-19: time to close the chapter
por: Gupta, Anunay, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine for cancer therapy
por: Manic, Gwenola, et al.
Publicado: (2014)

Reported ADRs with chloroquine or hydroxychloroquine
Publicado: (2021)

Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
por: Stevens, David M., et al.
Publicado: (2020)

Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine
por: Sahraei, Zahra, et al.
Publicado: (2020)

Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19
por: Li, Qiuyu, et al.
Publicado: (2021)

Janus sword actions of chloroquine and hydroxychloroquine against COVID-19
por: Chen, Xuesong, et al.
Publicado: (2020)

Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
por: Babayeva, Mariana, et al.
Publicado: (2020)

Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19
por: Zou, Li, et al.
Publicado: (2020)

Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?
por: Ibáñez, Sebastián, et al.
Publicado: (2020)

Chloroquine and Hydroxychloroquine Retinal Toxicity Consideration in the Treatment of COVID-19
por: Ruamviboonsuk, Paisan, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19
por: Lei, Zi-Ning, et al.
Publicado: (2020)

RETRACTED: Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous?
por: Funck-Brentano, Christian, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story
por: Gasmi, Amin, et al.
Publicado: (2021)

Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery
por: Chen, Yao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1bmne9l97ook8qhaa3nivuahkg